Renal Thrombotic Microangiopathy Associated with the Use of Bortezomib in a Patient with Multiple Myeloma

Bortezomib is a first-generation proteasome inhibitor used in the treatment of multiple myeloma (MM). A few reports have linked bortezomib exposure with the development of thrombotic microangiopathy (TMA). We describe a case of biopsy-proven renal thrombotic microangiopathy associated with the use o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Case Rep Hematol
Main Authors: Van Keer, Jan, Delforge, Michel, Dierickx, Daan, Peerlinck, Kathelijne, Lerut, Evelyne, Sprangers, Ben
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2016
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4884801/
https://ncbi.nlm.nih.gov/pubmed/27293920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6020691
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados